{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:47:57Z","timestamp":1792558077605,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:00:00Z","timestamp":1543795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41589-018-0160-y","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T10:35:04Z","timestamp":1543487704000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor"],"prefix":"10.1038","volume":"15","author":[{"given":"Martin","family":"Audet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Billy","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zarzycka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gye Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Gati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9393-2880","authenticated-orcid":false,"given":"Alexander","family":"Batyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Velasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Manahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Weierstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-4505","authenticated-orcid":false,"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-3914","authenticated-orcid":false,"given":"Vadim","family":"Cherezov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4522-8725","authenticated-orcid":false,"given":"Raymond C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,3]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti, E. & FitzGerald, G. A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986\u20131000 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","volume":"63","author":"DF Woodward","year":"2011","unstructured":"Woodward, D. F., Jones, R. L. & Narumiya, S. International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol. Rev. 63, 471\u2013538 (2011).","journal-title":"Pharmacol. Rev."},{"key":"160_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang, D. & Dubois, R. N. Eicosanoids and cancer. Nat. Rev. Cancer 10, 181\u2013193 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrd2957","volume":"9","author":"AD Michelson","year":"2010","unstructured":"Michelson, A. D. Antiplatelet therapies for the treatment of cardiovascular disease. Nat. Rev. Drug. Discov. 9, 154\u2013169 (2010).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1111\/bph.13331","volume":"172","author":"G O'Callaghan","year":"2015","unstructured":"O'Callaghan, G. & Houston, A. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? Br. J. Pharmacol. 172, 5239\u20135250 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"160_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","volume":"70","author":"CM Hao","year":"2008","unstructured":"Hao, C.-M. & Breyer, M. D. Physiological regulation of prostaglandins in the kidney. Annu. Rev. Physiol. 70, 357\u2013377 (2008).","journal-title":"Annu. Rev. Physiol."},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","volume":"22","author":"T Markovi\u010d","year":"2017","unstructured":"Markovi\u010d, T., Jakopin, \u017d., Dolenc, M. S. & Mlinari\u010d-Ra\u0161\u010dan, I. Structural features of subtype-selective EP receptor modulators. Drug Discov. Today 22, 57\u201371 (2017).","journal-title":"Drug Discov. Today"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jc.2011-1991","volume":"97","author":"S Arulkumaran","year":"2012","unstructured":"Arulkumaran, S. et al. The roles of prostaglandin EP 1 and 3 receptors in the control of human myometrial contractility. J. Clin. Endocrinol. Metab. 97, 489\u2013498 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/en.2013-1761","volume":"155","author":"MK Kandola","year":"2014","unstructured":"Kandola, M. K. et al. EP2 receptor activates dual G protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium. Endocrinology 155, 605\u2013617 (2014).","journal-title":"Endocrinology"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(10)60750-7","volume":"375","author":"M Potts","year":"2010","unstructured":"Potts, M., Prata, N. & Sahin-Hodoglugil, N. N. Maternal mortality: one death every 7\u2009min. Lancet 375, 1762\u20131763 (2010).","journal-title":"Lancet"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0140-6736(10)60348-0","volume":"375","author":"M Widmer","year":"2010","unstructured":"Widmer, M. et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 375, 1808\u20131813 (2010).","journal-title":"Lancet"},{"key":"160_CR12","first-page":"159","volume":"2","author":"R Allen","year":"2009","unstructured":"Allen, R. & O\u2019Brien, B. M. Uses of misoprostol in obstetrics and gynecology. Rev. Obstet. Gynecol. 2, 159\u2013168 (2009).","journal-title":"Rev. Obstet. Gynecol."},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF01297024","volume":"36","author":"BS Tsai","year":"1991","unstructured":"Tsai, B. S., Kessler, L. K., Stolzenbach, J., Schoenhard, G. & Bauer, R. F. Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid. Dig. Dis. Sci. 36, 588\u2013593 (1991).","journal-title":"Dig. Dis. Sci."},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"e0170739","DOI":"10.1371\/journal.pone.0170739","volume":"12","author":"N Orobaton","year":"2017","unstructured":"Orobaton, N. et al. Implementing at-scale, community-based distribution of misoprostol tablets to mothers in the third stage of labor for the prevention of postpartum haemorrhage in Sokoto State, Nigeria: early results and lessons learned. PLoS One 12, e0170739 (2017).","journal-title":"PLoS One"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.tips.2016.09.009","volume":"37","author":"J Xiang","year":"2016","unstructured":"Xiang, J. et al. Successful strategies to determine high-resolution structures of GPCRs. Trends Pharmacol. Sci. 37, 1055\u20131069 (2016).","journal-title":"Trends Pharmacol. Sci."},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1111\/bph.13452","volume":"173","author":"T Ngo","year":"2016","unstructured":"Ngo, T. et al. Identifying ligands at orphan GPCRs: current status using structure-based approaches. Br. J. Pharmacol. 173, 2934\u20132951 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"160_CR17","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. in Methods in Neurosciences. Vol. 25 (ed. Sealfon, S.C.) 366\u2013428 (Academic Press, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1432-1033.1995.tb20223.x","volume":"228","author":"A Schmid","year":"1995","unstructured":"Schmid, A., Thierauch, K. H., Schleuning, W. D. & Dinter, H. Splice variants of the human EP3 receptor for prostaglandin E2. Eur. J. Biochem. 228, 23\u201330 (1995).","journal-title":"Eur. J. Biochem."},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","volume":"547","author":"T Hua","year":"2017","unstructured":"Hua, T. et al. Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547, 468\u2013471 (2017).","journal-title":"Nature"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","volume":"167","author":"T Hua","year":"2016","unstructured":"Hua, T. et al. Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750\u2013762.e14 (2016).","journal-title":"Cell"},{"key":"160_CR21","doi-asserted-by":"crossref","first-page":"13475","DOI":"10.1074\/jbc.272.21.13475","volume":"272","author":"L Audoly","year":"1997","unstructured":"Audoly, L. & Breyer, R. M. The second extracellular loop of the prostaglandin EP3 receptor is an essential determinant of ligand selectivity. J. Biol. Chem. 272, 13475\u201313478 (1997).","journal-title":"J. Biol. Chem."},{"key":"160_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/mol.51.1.61","volume":"51","author":"L Audoly","year":"1997","unstructured":"Audoly, L. & Breyer, R. M. Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding and signal transduction of the prostaglandin EP3 receptor. Mol. Pharmacol. 51, 61\u201368 (1997).","journal-title":"Mol. Pharmacol."},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1124\/mol.59.6.1446","volume":"59","author":"MD Ungrin","year":"2001","unstructured":"Ungrin, M. D. et al. Key structural features of prostaglandin E2 and prostanoid analogs involved in binding and activation of the human EP1 prostanoid receptor. Mol. Pharmacol. 59, 1446\u20131456 (2001).","journal-title":"Mol. Pharmacol."},{"key":"160_CR24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","volume":"335","author":"MA Hanson","year":"2012","unstructured":"Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851\u2013855 (2012).","journal-title":"Science"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.abb.2016.12.001","volume":"616","author":"H Akasaka","year":"2017","unstructured":"Akasaka, H. et al. The key residue within the second extracellular loop of human EP3 involved in selectively turning down PGE2- and retaining PGE1-mediated signaling in live cells. Arch. Biochem. Biophys. 616, 20\u201329 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","volume":"1483","author":"M Abramovitz","year":"2000","unstructured":"Abramovitz, M. et al. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483, 285\u2013293 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"160_CR27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjp.0701367","volume":"122","author":"M Kiriyama","year":"1997","unstructured":"Kiriyama, M. et al. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 122, 217\u2013224 (1997).","journal-title":"Br. J. Pharmacol."},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0090-6980(94)90028-0","volume":"48","author":"M Negishi","year":"1994","unstructured":"Negishi, M. et al. TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor. Prostaglandins 48, 275\u2013283 (1994).","journal-title":"Prostaglandins"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature13494","volume":"513","author":"A Srivastava","year":"2014","unstructured":"Srivastava, A. et al. High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875. Nature 513, 124\u2013127 (2014).","journal-title":"Nature"},{"key":"160_CR30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0167-4889(93)90227-G","volume":"1175","author":"M Negishi","year":"1993","unstructured":"Negishi, M. et al. Functional interaction of prostaglandin E receptor EP3 subtype with guanine nucleotide-binding proteins, showing low-affinity ligand binding. Biochim. Biophys. Acta 1175, 343\u2013350 (1993).","journal-title":"Biochim. Biophys. Acta"},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0090-6980(93)90008-U","volume":"46","author":"M Hamon","year":"1993","unstructured":"Hamon, M. et al. Modulation of human myometrial PGE2 receptor by GTP characterization of receptor subtype. Prostaglandins 46, 251\u2013268 (1993).","journal-title":"Prostaglandins"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9343(87)90572-9","volume":"83","author":"BS Tsai","year":"1987","unstructured":"Tsai, B. S., Kessler, L. K., Schoenhard, G., Collins, P. W. & Bauer, R. F. Demonstration of specific E-type prostaglandin receptors using enriched preparations of canine parietal cells and [3H]misoprostol free acid. Am. J. Med. 83, 9\u201314 (1987).","journal-title":"Am. J. Med."},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature25773","volume":"555","author":"YL Liang","year":"2018","unstructured":"Liang, Y. L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex. Nature 555, 121\u2013125 (2018).","journal-title":"Nature"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"25624","DOI":"10.1074\/jbc.M110.115196","volume":"285","author":"E Goupil","year":"2010","unstructured":"Goupil, E. et al. A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho\/ROCK signaling pathway. J. Biol. Chem. 285, 25624\u201325636 (2010).","journal-title":"J. Biol. Chem."},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"e34729","DOI":"10.7554\/eLife.34729","volume":"7","author":"P Popov","year":"2018","unstructured":"Popov, P. et al. Computational design of thermostabilizing point mutations for G protein-coupled receptors. eLife 7, e34729 (2018).","journal-title":"eLife"},{"key":"160_CR36","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nat. Protoc. 4, 706\u2013731 (2009).","journal-title":"Nat. Protoc."},{"key":"160_CR37","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/nprot.2014.141","volume":"9","author":"W Liu","year":"2014","unstructured":"Liu, W., Ishchenko, A. & Cherezov, V. Preparation of microcrystals in lipidic cubic phase for serial femtosecond crystallography. Nat. Protoc. 9, 2123\u20132134 (2014).","journal-title":"Nat. Protoc."},{"key":"160_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4309","volume":"5","author":"U Weierstall","year":"2014","unstructured":"Weierstall, U. et al. Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography. Nat. Commun. 5, 3309 (2014).","journal-title":"Nat. Commun."},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1107\/S1600576714007626","volume":"47","author":"A Barty","year":"2014","unstructured":"Barty, A. et al. Cheetah: software for high-throughput reduction and analysis of serial femtosecond X-ray diffraction data. J. Appl. Crystallogr. 47, 1118\u20131131 (2014).","journal-title":"J. Appl. Crystallogr."},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1107\/S0021889812002312","volume":"45","author":"TA White","year":"2012","unstructured":"White, T. A. et al. CrystFEL: a software suite for snapshot serial crystallography. J. Appl. Crystallogr. 45, 335\u2013341 (2012).","journal-title":"J. Appl. Crystallogr."},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"160_CR42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D. Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"160_CR43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1107\/S0907444911056058","volume":"68","author":"OS Smart","year":"2012","unstructured":"Smart, O. S. et al. Exploiting structure similarity in refinement: automated NCS and target-structure restraints in BUSTER. Acta Crystallogr. D. Biol. Crystallogr. 68, 368\u2013380 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"160_CR44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"160_CR45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"160_CR46","doi-asserted-by":"crossref","first-page":"12769","DOI":"10.1073\/pnas.1413456111","volume":"111","author":"MR Sawaya","year":"2014","unstructured":"Sawaya, M. R. et al. Protein crystal structure obtained at 2.9\u2009\u00c5 resolution from injecting bacterial cells into an X-ray free-electron laser beam. Proc. Natl. Acad. Sci. USA 111, 12769\u201312774 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"160_CR47","doi-asserted-by":"crossref","first-page":"D370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370\u2013D376 (2012).","journal-title":"Nucleic Acids Res."},{"key":"160_CR48","unstructured":"PyMOL: The PyMOL Molecular Graphics System, Version 2.0 (Schr\u00f6dinger, LLC., 2015)."},{"key":"160_CR49","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1021\/ac401732d","volume":"85","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-\u03b2-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography\/mass spectrometry approaches. Anal. Chem. 85, 7957\u20137965 (2013).","journal-title":"Anal. Chem."}],"updated-by":[{"DOI":"10.1038\/s41589-018-0214-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000}}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0160-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-018-0160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:26:30Z","timestamp":1684621590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-018-0160-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1038\/s41589-018-0160-y","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41589-018-0214-1","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,3]]},"assertion":[{"value":"24 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article originally published, the present address for Petr Popov was incorrectly listed as \u2018Koltech Institute of Science & Technology, Moscow, Russia\u2019. The correct present address is \u2018Skolkovo Institute of Science and Technology, Moscow, Russia\u2019. The error has been corrected in the HTML and PDF versions of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.B is an employee of Domain Therapeutics NA, a company focused on GPCR drug discovery that sells and licenses the cell signaling kit used in this study. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}